TRYNGOLZA™ (olezarsen) approved in U.S. as first-ever treatment for adults living with ...
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has approved TRYNGOLZA™ (olezarsen) as an adjunct to diet to reduce triglycerides in adults ...
Winnipeg Free Press17 小时
Kinew’s tax dilemma: will he play politics or do what’s right?
They have tried to calculate the average savings from the tax and also done a public opinion survey that they say showed 80 ...
Dentistry18 小时
How has the October budget impacted practice sales?
Dental regional manager Simon Cosgrove discusses how the October 2024 budget has impacted practice ownership and sales.
MarketBeat on MSN10 小时
Darden Restaurants Earnings Transcript (NYSE:DRI)
Presentation Operator Greetings, and welcome to the Darden Restaurants, Inc. Q2 Fiscal Year 2025 Earnings Conference Call and ...
Check if you could get weight loss injections on the NHS
A new weight loss treatment known as tripeptide (Mounjaro) is expected to be rolled out via the NHS in March 2025 ...
NHS tool helps check if you're eligible for weight loss injections
A new weight loss treatment known as tripeptide (Mounjaro) is expected to be rolled out via the NHS in March 2025 ...
Long-delayed sentencing of Navy veteran convicted alongside Oath Keepers leader likely to ...
Thomas Caldwell, 69, of Berryville, Virginia, faces sentencing on one felony count of tampering with documents for destroying messages after Jan. 6.
Kosmos Energy: Not The Time To Buy Tullow, Catalyst Around The Corner
Kosmos Energy is poised for a major transformation with new projects increasing production and reducing CapEx. Read why KOS stock is a Strong Buy.